Postdiagnostic statin use and the risk of lethal prostate cancer in the health professionals follow-up study

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1638-1640

  Chan, June M ^a   Kenfield, Stacey A ^a   Paciorek, Alan ^a   Platz, Elizabeth A ^b   Giovannucci, Edward L ^c   Stampfer, Meir J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; DRUG USE; FOLLOW UP; HUMAN; LETHAL PROSTATE CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; CANCER GRADING; CLINICAL TRIAL; DISEASE COURSE; HEALTH CARE PERSONNEL; INCIDENCE; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME FACTOR; TRENDS; UNITED STATES;

AGED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84942875898     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0671     Document Type: Article

References (8)

1. Yu O, Eberg M, Benayoun S, Aprikian A, Batist G, Suissa S, et al. Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol 2014; 32:5-11.
2. Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, et al. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: A systematic review and meta-analysis. Ann Oncol 2013;24: 1427-34.
3. Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, et al. Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006;98:1819-25.
4. Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU Int 2013;111:954-62.
5. Algotar AM, Thompson PA, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, et al. Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. Prostate 2010;70:883-8.
6. Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, et al. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int 2014;114:661-6.
7. Marcella SW, David A, Ohman-Strickland PA, Carson J, Rhoads GG. Statin use and fatal prostate cancer: A matched case-control study. Cancer 2012; 118:4046-52.
8. Geybels MS, Wright JL, Holt SK, Kolb S, Feng Z, Stanford JL. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study. Prostate 2013;73:1214-22.